Press Release
HAPPE Spine Announces Close Of $3.35 Million Round In Series A Investment
HAPPE Spine announces that it has closed on a $3.35 million Series A capital raise.
Press Release
World’s First Surgery Using Virtual Incision’s MIRA Miniature Robotic System Performed at Bryan Medical Center in Lincoln, Nebraska
Company Begins IDE Study, Advancing Goal of Bringing Robotically Assisted Surgery to Any U.S. Hospital or Ambulatory Surgery Center
Press Release
SpinTech Receives FDA 510(K) Clearance for STAGE™ Technology
HOLLAND, Mich., August 9th, 2021—Genesis Innovation Group’s cultivate(MD) Capital Fund II LP, a fund focused on investments into early-stage healthcare companies with innovative technologies, announced
News
New $30M VC fund aims to get medical devices to market
GRAND RAPIDS — A venture capital firm that invests in medical device technologies wants to raise $30 million for a new fund to support portfolio
Press Release
cultivate(MD) Announces Investment Into Medical Ingenuities
HOLLAND, Mich., May 24, 2021 – Genesis Innovation Group\’s cultivate(MD) Seed II Fund, a fund focused on investments into early-stage healthcare companies with innovative technologies,
Press Release
Shoulder Innovations Announces Exclusive License Agreement for Genesis Software Innovations PreView Shoulder™ Software
HOLLAND, Mich., May 10th, 2021 – Shoulder Innovations (SI), an emerging leader in the development of shoulder replacement systems, announced today that it has signed
Press Release
Genesis Software Innovations Announces FDA 510(K) Clearance for Preview™ 3D Shoulder Arthroplasty Planning Software
GRAND RAPIDS, Mich., May 5th, 2021—Genesis Software Innovations “GSI,” a company that has created an innovative foundational platform solution in the orthopedic space, announced today
News
cultivate(MD) Accelerator Fund
cultivate(MD)’s Seed Funds have demonstrated strong progress and performance, and it is now time to launch our new Accelerator Fund.
Press Release
Medical Ingenuities Receives FDA 510(k) Clearance for PH Band
Novel radial artery occlusion device removes the guesswork from achieving Patent Hemostasis Holland, Mich. – December 9th, 2020 – Genesis Innovation Group’s cultivate(MD) Capital Fund
News
An Interview with E. Mark Haacke, Ph.D.
Matt Ahearn: Thanks for joining us today Dr. Haacke. Will you provide us with an overview of STAGE is and how it works? Dr. Haacke:
